Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis
Frontiers in Pharmacology · 11.12.2025 · 16
DOI: 10.3389/fphar.2025.1678203 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.12.2025. Verfasst von Juan Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Internal Medicine, The Second Xiangya Hospital, Central South University, Changsha, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Correction on: Duan J, Hu X, Li T, Wu G, Dou P, Ouyang Z. Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis. Front Pharmacol. 2021;12:724256. doi:10.3389/fphar.2021.724256..Wrong content There was a mistake in Figure 1E (80 μM group) and Figure 2C (80 μM group) as published. Due to an error during figure preparation, the image used for the 80 μM group in Figure 1E (TRAP staining of BMMs) and the 80 μM group in Figure 2C (F-actin immunofluorescence) were incorrect and do not represent the appropriate experimental data. The corrected Figure 1 and Figure 2 appears below. These changes do not affect the scientific conclusions of the article in any way. The authors apologize for this error and any confusion it may have caused.for a reason not seen here, please contact the journal's editorial office.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Internal Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
- Deparment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Zitieren
APA
Duan, J., Hu, X., Li, T., Wu, G., Dou, P., & Ouyang, Z. (2025). Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1678203
Vancouver
Duan J, Hu X, Li T, Wu G, Dou P, Ouyang Z. Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1678203
BibTeX
@article{Duan2025,
author = {Duan, Juan and Hu, Xuantao and Li, Tao and Wu, Gen and Dou, Pengcheng and Ouyang, Zhengxiao},
title = {Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1678203}
}
EUVIMED